We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Faron Pharmaceuticals Oy | LSE:FARN | London | Ordinary Share | FI4000153309 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.50 | 1.96% | 130.00 | 125.00 | 135.00 | 130.00 | 127.50 | 127.50 | 825 | 10:11:47 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -28.73M | -0.4177 | -3.11 | 89.42M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/2/2020 18:08 | I am new to the details of the company so I'm afraid I wasn't looking for such subtleties as body language! He did mention corona virus but nothing definitive. And I don't know the history of steroids in SNG's studies. After hearing about the problems with Traumakine I went and looked at the SGN trial and was pleased to see it was an exclusion criteria but I don't know the reason why. | nobbygnome | |
08/2/2020 18:00 | Nobby. Thanks. Did Markku mention Corona Virus? Body language when speaking about the FDA feedback? Synairgen. I am not familiar with the product or company. Do you know if there was any evidence that steroids caused more harm than good in this indication? TIA | hashertu | |
08/2/2020 15:01 | I heard the presentation on Thursday at Proactive. I have to say I am quite impressed with the Clevegen antibody and was interested to hear the results of the ongoing open label trial will be released in March. From what I saw and my knowledge of a similar drug, I think it has a good chance of working. So FARN might be worth a punt on the back of this result and I will be watching for a suitable buy point. Just a comment about Traumakine and the steroid issue. Synairgen clearly got to grips with this problem because in their ongoing inhaled beta interferon trial in COPD with viral infections they excluded patients who had been on oral steroids in the last 6 weeks. I think that trial has a very high chance of a successful outcome.... | nobbygnome | |
06/2/2020 09:44 | Daffodil4. My understanding is that Faron have only just submitted a revised plan based on feedback. This feedback included: "The trial protocol has been amended to reflect the FDA's feedback that further studies with interferon-beta (IFN-beta) should exclude the use of overlapping steroids". I think this is very significant news. Also, a suggestion (no more) that Traumakine might have some application treating some patients suffering from Corona Virus (I have no idea how much Traumakine is available to even contemplate this step). | hashertu | |
06/2/2020 08:50 | If as Faron have said the trial only failed because they used steroids.. why did the FDA not agree another Phase 3 trial now ...there is obviously another isssue...the RNS gives no detail at all of what the FDA advised...!!! | daffodil4 | |
06/2/2020 08:32 | Big positives here IMO out of something initially that could have been potentially seen as a negative! DL | davidlloyd | |
03/2/2020 08:02 | hasertu N.. I totally disagree. Faron have to release price sensitive news, and now 2 months on from the meeting the minutes will have been received and should be released. The matter of arbitration is completely separate...it is a question of a contract being broken, nothing to do with FDA approval. | daffodil4 | |
31/1/2020 14:51 | Daffodil4. It is possible that the arbitration issue with Rentschler has a bearing on, and thus delayed, any news of the FDA meeting outcome. As a third party is providing litigation funding, I imagine they have a major say in any news release about anything to do with Traumakine. | hashertu | |
30/1/2020 14:39 | Apols...should have said due within 30 days not after.. We are well over the due date... | daffodil4 | |
30/1/2020 12:43 | If due after 30 days, surely that's very open ended and could take 60 days.Also can't see how they could hold back on market sensitive news, when it's coming from the FDA !!! | bwgs | |
30/1/2020 09:39 | The minutes from the FDA meeting were due after 30 days so Faron definitely have them by now. It is price sensitive news and shareholders should have been notfied by now...... They are witholding this information.. if it was positive there would be no reason to do that.. IMO! | daffodil4 | |
27/1/2020 09:51 | Is this the first move into the USA for Clevegen? | hashertu | |
22/1/2020 12:47 | Hi hasertu There have been other successes where terminal patients are now cancer free...very exciting progress. I agree Clevegen has great promise..early days let's see! Re Traumakine, I know other drugs are in trial, not sure how they are progressing. It remains an area that needs a successful treatment.....my gut says it will need further data before another trial is agreed but who knows! I do think the outcome is known now.. but still need a backer for another trial and someone to manufacture the drug....so a few hurdles to overcome. I have been in OXB a long time ago..will take another look.Thanks! GL. | daffodil4 | |
21/1/2020 18:09 | Daffodil4. Are you referring to the documentary "War in the blood"? If you to know more, have a look at the OXB BB, to see the collaboration with Novartis. Using T cells is, without doubt a hot topic. However, so is Clevegen, in my mind. Which will be the commercial success? Who knows? Cure all cancers? In the programme I saw, two patients died because the cancer evolved. Makes for a good headline to attract readers/viewers, but should taken with a pinch of salt. I doubt the medical community said that. As to Traumakine/FDA, I do not expect a quick decision. It is no simple matter to ditch conventional treatment in favour of an untried approach. | hashertu | |
21/1/2020 10:53 | FDA meeting to request permission to do another phase 3 trial on Traumakine that took place at beginning of December. Faron said they are waiting for the minutes so they can update shareholders...but IMO they must know what has been agreed by now. Have a feeling they will not get permission.. Someone is definitely offloading steadily to not cause a panic sell off... Also everyone should watch last nights Panorama...a new treatment using patients own cells to attack the cancer is showing potential to cure all types of cancer.. so this could have a massive impact on ALL other cancer drugs as they could be obsolete before they are even tested... If as I beiieve Faron is really all about Clevegen now..this is a significant developement. GLA! | daffodil4 | |
21/1/2020 10:01 | Daffodil4. Which meeting are you referring to? | hashertu | |
20/1/2020 10:44 | Surely the minutes are available by now on Traumakine meeting? I think the news may disappoint.. | daffodil4 | |
12/1/2020 08:33 | Everything to play for:) | bmnsa | |
31/12/2019 16:23 | 2020 Farn are back on track, hold on to your hard, Hona be a great one. | bwgs |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions